synairgen.png
Synairgen announces its inhaled interferon beta (SNG001) is advancing to Phase 3 of the NIH-sponsored ACTIV-2 COVID-19 Trial
October 20, 2021 07:00 ET | Synairgen plc
Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces its inhaled interferon beta (SNG001) is advancing to Phase 3 of the NIH-sponsored ACTIV-2 COVID-19 Trial Southampton, UK – 20 October...
synairgen.png
Non-Executive Director Appointment
September 30, 2021 07:00 ET | Synairgen plc
Synairgen plc(‘Synairgen’ or the ‘Company’) Non-Executive Director Appointment Southampton, UK – 30 September 2021: Synairgen plc (LSE: SNG), the drug discovery, development and commercialisation...
synairgen.png
Interim results for the six months ended 30 June 2021
September 30, 2021 07:00 ET | Synairgen plc
Synairgen plc(‘Synairgen’ or the ‘Company’) Interim results for the six months ended 30 June 2021 Scaling up and preparing for Phase III COVID-19 trial data read-out Webcast today at 13:00 BST ...
synairgen.png
Non-Executive Director Appointment
September 30, 2021 02:02 ET | Synairgen plc
Synairgen plc(‘Synairgen’ or the ‘Company’) Non-Executive Director Appointment Southampton, UK – 30 September 2021: Synairgen plc (LSE: SNG), the drug discovery, development and commercialisation...
synairgen.png
Interim results for the six months ended 30 June 2021
September 30, 2021 02:01 ET | Synairgen plc
Synairgen plc(‘Synairgen’ or the ‘Company’) Interim results for the six months ended 30 June 2021 Scaling up and preparing for Phase III COVID-19 trial data read-out Webcast today at 13:00 BST ...
synairgen.png
Preliminary results for the year ended 31 December 2020
May 12, 2021 07:00 ET | Synairgen plc
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Preliminary results for the year ended 31 December 2020 Significant progress continues towards a treatment for COVID-19 ...
synairgen.png
Preliminary results for the year ended 31 December 2020
May 12, 2021 02:00 ET | Synairgen plc
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Preliminary results for the year ended 31 December 2020 Significant progress continues towards a treatment for COVID-19 Southampton, UK –...
synairgen.png
Synairgen plc - Interim results for the six months ended 30 June 2020
September 29, 2020 07:00 ET | Synairgen plc
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Interim results for the six months ended 30 June 2020 Southampton, UK – 29 September 2020: Synairgen plc (LSE: SNG), the respiratory drug...
synairgen.png
Synairgen plc: Preliminary results for the year ended 31 December 2019
May 26, 2020 07:00 ET | Synairgen plc
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Preliminary results for the year ended 31 December 2019 Southampton, UK – 26 May 2020: Synairgen plc (LSE: SNG), the respiratory drug...
synairgen.png
Synairgen plc - Update on expanded SG016 trial for patients with COVID-19:Synairgen initiates dosing of SNG001 in home setting to treat patients earlier in the illness
May 26, 2020 07:00 ET | Synairgen plc
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Update on expanded SG016 trial for patients with COVID-19:Synairgen initiates dosing of SNG001 in home setting to treat patients earlier in...